Αποτελέσματα Αναζήτησης
1 Οκτ 2003 · The Antihypertensive Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) just published, 1 is the largest clinical trial so far conducted.
1 Ιουν 2016 · Our protocols have identified certain adverse events (AEs) e.g. stroke, or heart attack, which may occur during follow-up and which should be reported as "outcomes" rather than via the AE ...
In patients with acute chest pain and suspected ACS who are deemed low-risk (<1% 30-day risk of death or MACE), it is reasonable to discharge home without admission or urgent cardiac testing . Synopsis
19 Απρ 2000 · The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) is a randomized, double-blind, active-controlled trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI).
The Antihypertensive and Lipid-Lowering Treatment to Pre-vent Heart Attack Trial (ALLHAT), sponsored by the Na-tional Heart, Lung, and Blood Institute (NHLBI), is the largest outcome trial of antihypertensive treatment ever car-ried out and the only large blood pressure (BP) trial to be carried out in a US population in the past decade.1 The rat...
Recent meta-analyses that analyzed 10 RCTs including the COMPLETE trial confirmed the robust benefit of PCI of the non-culprit lesion to reduce cardiovascular death, recurrent MI, and unplanned revascularization .
8 Αυγ 2023 · Review the basic pathophysiology of myocardial infarction. Explain the management protocol when presented with acute myocardial infarction, including all necessary laboratory and other diagnostic testing. Summarize the long-term management and rehabilitation for a patient post-MI.
